Unraveling the Mystery of Erythropoietin-Stimulating Agents in Cancer Promotion
نویسندگان
چکیده
Erythropoietin-stimulating agents (ESA) are approved for use in treating chemotherapy-induced anemia in patients with nonmyeloid malignancies. However, recent clinical trials have shown evidence of inferior overall survival and/or locoregional control of tumors in patients receiving ESAs. Given these concerning data, current studies are focused on elucidating the biological mechanisms by which ESAs may contribute to cancer promotion. Evidence suggests that ESAs activate several signaling pathways that are important in altering tumor behavior and response to treatment. Although further research is needed to more precisely elucidate these mechanisms, caution should be exercised in the use of ESAs beyond their approved indication in cancer patients. [Cancer Res 2008; 68(11):4013–17]
منابع مشابه
The effect of erythropoietin on normal and neoplastic cells
Erythropoietin (Epo) is an essential hormone that binds and activates the Epo receptor (EpoR) resident on the surface of erythroid progenitor cells, thereby promoting erythropoiesis. Recombinant human erythropoietin has been used successfully for over 20 years to treat anemia in millions of patients. In addition to erythropoiesis, Epo has also been reported to have other effects, such as tissue...
متن کاملMolecular Pathways The Role of Erythropoietin and Erythropoiesis-Stimulating Agents in Tumor Progression
Over the past few decades, understanding of the physiologic function of erythropoietin (EPO) has evolved significantly. EPO binds to erythropoietin receptors (EPOR), initiating signaling that stimulates growth, inhibits apoptosis, and induces the differentiation of erythroid progenitors to increase red blood cell mass. EPO has additionally been shown to exert tissue-protective effects on multip...
متن کاملUnraveling the Effects of Process Control Agents on Mechanical Alloying of Nanostructured Cu-Fe Alloy
Nanostructured Cu-20Fe alloy was synthesized by mechanical alloying process and the effects of process control agents (PCA) on the phase formation, crystallite refinement and morphology of powder particles were studied. The dissolution of Fe into Cu matrix and the morphology of powder particles were analyzed by X-ray diffraction (XRD) technique and scanning electron microscopy (SEM), respective...
متن کاملErythropoiesis-stimulating agents: benefits and risks in supportive care of cancer
Anemia, already common in cancer patients, is often exacerbated by chemotherapy. Cancer patients who are anemic have been shown to have a blunted response for production of endogenous erythropoietin growth factor. This anemia can be corrected with exogenous erythropoietin growth factors, of which three available are worldwide: epoetin alfa, epoetin beta, and darbepoetin alfa. Collectively, thes...
متن کاملThe role of erythropoietin and erythropoiesis-stimulating agents in tumor progression.
Over the past few decades, understanding of the physiologic function of erythropoietin (EPO) has evolved significantly. EPO binds to erythropoietin receptors (EPOR), initiating signaling that stimulates growth, inhibits apoptosis, and induces the differentiation of erythroid progenitors to increase red blood cell mass. EPO has additionally been shown to exert tissue-protective effects on multip...
متن کامل